11.15.06
Kendle has appointed Sylva H. Collins, Ph.D. to vice president, global biometrics. Dr. Collins will oversee the company's biometrics services, which include clinical data management, biostatistics and scientific programming. She will also provide leadership for data centers in the U.S., Europe, Australia and Mexico staffed by more than 500 associates. She will serve on the company's management committee and will be based out of Kendle's headquarters in Cincinnati. Dr. Collins has scientific and management expertise, and is a recognized thought leader in the Electronic Data Capture (EDC) field.
"We are extremely pleased to welcome Dr. Collins to Kendle. Her forward thinking and proven leadership will keep Kendle's Biometrics services at the forefront of the industry," said Christopher Bergen, president and chief operating officer. "Her nearly three decades of experience in drug development and her extensive EDC experience will be significant assets as we continue to execute against our 'Kendle 500' global growth strategy."
Dr. Collins joins the company from Novartis Corp., where she served most recently as vice president, global advanced clinical systems, and vice president, global electronic data management. In these positions, she implemented and led the global data management operations for more than 400 EDC studies involving approximately 130,000 patients and 16,000 investigator sites on six continents.
"We are extremely pleased to welcome Dr. Collins to Kendle. Her forward thinking and proven leadership will keep Kendle's Biometrics services at the forefront of the industry," said Christopher Bergen, president and chief operating officer. "Her nearly three decades of experience in drug development and her extensive EDC experience will be significant assets as we continue to execute against our 'Kendle 500' global growth strategy."
Dr. Collins joins the company from Novartis Corp., where she served most recently as vice president, global advanced clinical systems, and vice president, global electronic data management. In these positions, she implemented and led the global data management operations for more than 400 EDC studies involving approximately 130,000 patients and 16,000 investigator sites on six continents.
